BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ma WJ, Wang X, Yan WT, Zhou ZG, Pan ZZ, Chen G, Zhang RX. Indoleamine-2,3-dioxygenase 1/cyclooxygenase 2 expression prediction for adverse prognosis in colorectal cancer. World J Gastroenterol 2018; 24(20): 2181-2190 [PMID: 29853736 DOI: 10.3748/wjg.v24.i20.2181]
URL: https://www.wjgnet.com/1007-9327/full/v24/i20/2181.htm
Number Citing Articles
1
Chengtao Sun, Mengzhen Li, Lian Zhang, Feifei Sun, Huimou Chen, Yanjie Xu, Yingxia Lan, Li Zhang, Suying Lu, Jia Zhu, Junting Huang, Juan Wang, Yang Hu, Yanfen Feng, Yizhuo Zhang. IDO1 plays a tumor-promoting role via MDM2-mediated suppression of the p53 pathway in diffuse large B-cell lymphomaCell Death & Disease 2022; 13(6) doi: 10.1038/s41419-022-05021-2
2
Xi-Zhen Sun, Dong-Yan Zhao, Yuan-Chen Zhou, Qian-Qian Wang, Geng Qin, Shu-Kun Yao. Alteration of fecal tryptophan metabolism correlates with shifted microbiota and may be involved in pathogenesis of colorectal cancerWorld Journal of Gastroenterology 2020; 26(45): 7173-7190 doi: 10.3748/wjg.v26.i45.7173
3
Hanna Elomaa, Jouni Härkönen, Sara A. Väyrynen, Maarit Ahtiainen, Shuji Ogino, Jonathan A. Nowak, Mai Chan Lau, Olli Helminen, Erkki-Ville Wirta, Toni T. Seppälä, Jan Böhm, Jukka-Pekka Mecklin, Teijo Kuopio, Juha P. Väyrynen. Quantitative Multiplexed Analysis of Indoleamine 2,3-Dioxygenase (IDO) and Arginase-1 (ARG1) Expression and Myeloid Cell Infiltration in Colorectal CancerModern Pathology 2024; 37(4): 100450 doi: 10.1016/j.modpat.2024.100450
4
Milene Gonçalves, Alessia Furgiuele, Emanuela Rasini, Massimiliano Legnaro, Marco Ferrari, Alessandra Luini, Paulo Rodrigues-Santos, Francisco Caramelo, Franca Marino, Frederico C. Pereira, Marco Cosentino. A peripheral blood mononuclear cell-based in vitro model: A tool to explore indoleamine 2, 3-dioxygenase-1 (IDO1)European Journal of Pharmacology 2024; 968: 176420 doi: 10.1016/j.ejphar.2024.176420
5
T. Gambichler, L. Selke, I. Rüddel, M. Dreißigacker, E. Stockfleth, L. Schmitz. Expression of indolamine‐2,3‐dioxygenase and cyclooxygenase‐2 in different disease stages of cutaneous squamous cell carcinomaJournal of the European Academy of Dermatology and Venereology 2019; 33(12) doi: 10.1111/jdv.15763
6
Christin Riess, Björn Schneider, Hanna Kehnscherper, Julia Gesche, Nina Irmscher, Fatemeh Shokraie, Carl Friedrich Classen, Elisa Wirthgen, Grazyna Domanska, Annette Zimpfer, Daniel Strüder, Christian Junghanss, Claudia Maletzki. Activation of the Kynurenine Pathway in Human Malignancies Can Be Suppressed by the Cyclin-Dependent Kinase Inhibitor DinaciclibFrontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.00055
7
Yong Liu, Youcheng Liang, Yongjian Su, Jiaqi Hu, Jianbo Sun, Mingbin Zheng, Zunnan Huang. Exploring the potential mechanisms of Yi-Yi-Fu-Zi-Bai-Jiang-San therapy on the immune-inflamed phenotype of colorectal cancer via combined network pharmacology and bioinformatics analysesComputers in Biology and Medicine 2023; 166: 107432 doi: 10.1016/j.compbiomed.2023.107432
8
Yu Toda, Kenichi Kohashi, Yuichi Yamada, Masato Yoshimoto, Shin Ishihara, Yoshihiro Ito, Takeshi Iwasaki, Hidetaka Yamamoto, Yoshihiro Matsumoto, Yasuharu Nakashima, Masaaki Mawatari, Yoshinao Oda. PD-L1 and IDO1 expression and tumor-infiltrating lymphocytes in osteosarcoma patients: comparative study of primary and metastatic lesionsJournal of Cancer Research and Clinical Oncology 2020; 146(10): 2607 doi: 10.1007/s00432-020-03242-6
9
Qi Yao, Xinqi Ge, Zhichao Lu, Jinlong Shi, Jianhong Shen, Jian Chen, Qingbin Cui. HAUS Augmin-Like Complex Subunit 1 Influences Tumour Microenvironment and Prognostic Outcomes in GliomaJournal of Oncology 2022; 2022: 1 doi: 10.1155/2022/8027686
10
Xi Jiang, Zhongxiu Jiang, Min Jiang, Yan Sun. Berberine as a Potential Agent for the Treatment of Colorectal CancerFrontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.886996
11
Ioannis M. Koukourakis, Kalliopi Platoni, Dina Tiniakos, Vassilis Kouloulias, Anna Zygogianni. Immune Response and Immune Checkpoint Molecules in Patients with Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy: A ReviewCurrent Issues in Molecular Biology 2023; 45(5): 4495 doi: 10.3390/cimb45050285
12
Sen Wang, Jia Wu, Han Shen, Junjun Wang. The prognostic value of IDO expression in solid tumors: a systematic review and meta-analysisBMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-06956-5
13
Yuki Kiyozumi, Yoshifumi Baba, Kazuo Okadome, Taisuke Yagi, Yoko Ogata, Kojiro Eto, Yukiharu Hiyoshi, Takatsugu Ishimoto, Masaaki Iwatsuki, Shiro Iwagami, Yuji Miyamoto, Naoya Yoshida, Masayuki Watanabe, Hideo Baba. Indoleamine 2, 3‐dioxygenase 1 promoter hypomethylation is associated with poor prognosis in patients with esophageal cancerCancer Science 2019; 110(6): 1863 doi: 10.1111/cas.14028
14
Miaoqing Wu, Xiaoliang Wu, Xing Wang, Xiangchan Hong, Yifan Liu, Guangzhao Lv, Cong Li, Zhizhong Pan, Rongxin Zhang, Gong Chen. IDO1/COX2 Expression Is Associated with Poor Prognosis in Colorectal Cancer Liver OligometastasesJournal of Personalized Medicine 2023; 13(3): 496 doi: 10.3390/jpm13030496
15
Claudia Maletzki, Philine Scheinpflug, Anika Witt, Ernst Klar, Michael Linnebacher. Targeting Immune-Related Molecules in Cancer Therapy: A ComprehensiveIn VitroAnalysis on Patient-Derived Tumor ModelsBioMed Research International 2019; 2019: 1 doi: 10.1155/2019/4938285